Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07161505 · ClinicalTrials.gov registry record · NA
Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior
A NA study of Approach/Avoidance Behavior, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT07161505 is a NA study of Approach/Avoidance Behavior that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07161505, a NA study of Approach/Avoidance Behavior, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the long-lasting effects of personalized theta burst stimulation (TBS), a repetitive form of transcranial magnetic stimulation (TMS), over the left prefrontal cortex on the approach/avoidance behavior. TBS will be personalized based on the prefrontal theta rhythm captured with electroencephalography (EEG). The main questions it aims to answer are: 1. does a single session of personalized TBS synchronized with the individual theta rhythm over the left prefrontal cortex results in the outlasting changes in the individual behavior? 2. Does TBS results in the brain rhythms' changes as measured using resting-state EEG?
Conditions Studied
Interventions
- DEVICE TBS-EEG
- DEVICE TBS-EEG / Spatial Control
- DEVICE TBS / Temporal Control
- DEVICE TBS-EEG / Dose Control
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-07-31 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07161505
The ClinicalTrials.gov registry entry for NCT07161505 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Approach/Avoidance Behavior appearing as the primary indexed condition, and to 4 interventions - of which TBS-EEG is the first listed.
NCT07161505 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07161505 about?
NCT07161505 is a clinical study titled "Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior". This study will assess the long-lasting effects of personalized theta burst stimulation (TBS), a repetitive form of transcranial magnetic stimulation (TMS), over the left prefrontal cortex on the approach/avoidance behavior. TBS will be personalized based on the prefrontal theta rhythm captured with...
What is the current status of trial NCT07161505?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2025-07-31. Estimated completion is 2026-08-31.
What conditions does trial NCT07161505 study?
This clinical trial studies the following conditions: Approach/Avoidance Behavior.
What interventions are being tested in trial NCT07161505?
The interventions under investigation include: TBS-EEG (DEVICE), TBS-EEG / Spatial Control (DEVICE), TBS / Temporal Control (DEVICE), TBS-EEG / Dose Control (DEVICE).
Who is sponsoring clinical trial NCT07161505?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07161505 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.